Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Valbiotis SAS

ALVAL
Current price
1.15 EUR -0.012 EUR (-1.03%)
Last closed 1.18 EUR
ISIN FR0013254851
Sector Healthcare
Industry Biotechnology
Exchange Euronext Paris
Capitalization 18 711 474 EUR
Yield for 12 month -81.74 %
1Y
3Y
5Y
10Y
15Y
ALVAL
21.11.2021 - 28.11.2021

Valbiotis SA engages in the research and development of health nutrition products to prevent and control metabolic and cardiovascular diseases in France. The company develops TOTUM-63 for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II/III clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with MASLD. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France. Address: rue Paul Vatine, Périgny, France, 17180

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.9 EUR

P/E ratio

Dividend Yield

Current Year

+4 753 223 EUR

Last Year

+788 354 EUR

Current Quarter

+35 150 EUR

Last Quarter

+492 094 EUR

Current Year

+2 008 546 EUR

Last Year

+770 277 EUR

Current Quarter

-928 952 EUR

Last Quarter

-1 576 708 EUR

Key Figures ALVAL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -8 921 457 EUR
Operating Margin TTM -88.8 %
PE Ratio
Return On Assets TTM -14.79 %
PEG Ratio
Return On Equity TTM -44.71 %
Wall Street Target Price 4.9 EUR
Revenue TTM 3 690 702 EUR
Book Value 1.25 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -1.5 %
Dividend Yield
Gross Profit TTM 2 826 024 EUR
Earnings per share -0.65 EUR
Diluted Eps TTM -0.65 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -243.37 %

Dividend Analytics ALVAL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALVAL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 112:111
Payout Ratio
Last Split Date 14.10.2019
Dividend Date

Stock Valuation ALVAL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 11.8127
Price Sales TTM 5.0699
Enterprise Value EBITDA -3.1362
Price Book MRQ 1.1087

Financials ALVAL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALVAL

For 52 weeks

1.07 EUR 6.53 EUR
50 Day MA 1.32 EUR
Shares Short Prior Month
200 Day MA 2.53 EUR
Short Ratio
Shares Short
Short Percent